About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Growth Hormone Drug Fails to Slow Progression of Alzheimer's

by VR Sreeraman on November 18, 2008 at 12:26 PM
 Growth Hormone Drug Fails to Slow Progression of Alzheimer's

A drug which increases the release of growth hormones has failed to slow the progression of Alzheimer's disease in humans, despite having offered promising results in studies on mice, a study published Tuesday has found.

Previous studies on mice had shown that a hormone called insulin-like growth factor-1 helped reduce the accumulation of plaque on the brain.

Advertisement

This plaque, called beta-amyloid, is thought to be an important cause of the memory and behavioral symptoms of Alzheimer's.

Researchers used an experimental drug to stimulate the release of growth hormone in 208 people who had mild to moderate Alzheimer's disease. Another 208 patients were given placebo pills during the year-long study.
Advertisement

They successfully managed to increase the level of growth hormone in the blood of those patients receiving the drug which then stimulated the release of the insulin-like growth factor-1 hormone.

However, the drug did not manage to slow the symptoms of the disease, the study published in the journal Neurology found.

"This work suggests that targeting this hormone system may not be an effective approach to slowing the rate of Alzheimer's disease progression," said study author J.J. Sevigny of Merck Research Laboratories in Pennsylvania.

"Importantly, it challenges the common theory that hormones may attack beta-amyloid plaque in the brain and builds on the body of clinical evidence for Alzheimer's disease as we seek to develop more effective treatments."

Source: AFP
SRM
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

Projected Growth: Psychedelic Drug Market Anticipated to Hit $7.2 Billion by 2029
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
ADHD Medication Errors Surge by Nearly 300%
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
Unknown Medication Side Effects Reported by 52% of Indian Families
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Growth Hormone Drug Fails to Slow Progression of Alzheimer's Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests